Lastly, we did not conduct the animal study of DO using inhibitors of FGFR3 signaling, although there have been several animal studies in which meclozine ameliorated bone mass in OVX mice [33] as well as a juvenile mouse model of FGFR3-related skeletal dysplasia [26]. This evidence concerns the gene FGFR3 and skeletal dysplasia.